Fujifilm Announces the Receipt of Imported Drug License for Its Oral Synthetic Quinolone Antibacterial Agent in China
July 25, 2019
July 25, 2019
VALHALLA, New York, July 25 -- Fujifilm USA issued the following news:
FUJIFILM Corporation (President: Kenji Sukeno) announces the receipt /1 of an imported drug license for the oral synthetic quinolone antibacterial agent "T-3811" (generic name: garenoxacin mesilate hydrate) from the National Medical Products Administration (NMPA) of China with respiratory infections such as pneumonia.
"T-3811" is a synthetic quinolone antibacterial agent developed . . .
FUJIFILM Corporation (President: Kenji Sukeno) announces the receipt /1 of an imported drug license for the oral synthetic quinolone antibacterial agent "T-3811" (generic name: garenoxacin mesilate hydrate) from the National Medical Products Administration (NMPA) of China with respiratory infections such as pneumonia.
"T-3811" is a synthetic quinolone antibacterial agent developed . . .